{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:17:32Z","timestamp":1785881852778,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.diabres.2024.111799","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T01:49:28Z","timestamp":1722304168000},"page":"111799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["High glutamic acid decarboxylase antibody titers may be associated with a decline in \u03b2-cell function over time and future insulin deficiency in latent autoimmune diabetes in adults"],"prefix":"10.1016","volume":"215","author":[{"given":"Akifumi","family":"Haisa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Satomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumpei","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Katsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2024.111799_b0005","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM198605223142106","article-title":"Type I diabetes mellitus. A chronic autoimmune disease","volume":"314","author":"Eisenbarth","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2024.111799_b0010","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/07853890008998833","article-title":"A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence","volume":"32","author":"Imagawa","year":"2000","journal-title":"Ann Med"},{"key":"10.1016\/j.diabres.2024.111799_b0015","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s00125-006-0213-8","article-title":"Type 1 diabetes in Japan","volume":"49","author":"Kawasaki","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2024.111799_b0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1297\/cpe.23.99","article-title":"Type 1 diabetes and autoimmunity","volume":"23","author":"Kawasaki","year":"2014","journal-title":"Clin Pediatr Endocrinol"},{"key":"10.1016\/j.diabres.2024.111799_b0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/jdi.12119","article-title":"Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): report of the committee of japan diabetes society on the research of fulminant and acute-onset type 1 diabetes mellitus","volume":"5","author":"Kawasaki","year":"2014","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.diabres.2024.111799_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13340-023-00679-1","article-title":"New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): report from committee on type 1 diabetes in japan diabetes society (English version)","volume":"15","author":"Shimada","year":"2024","journal-title":"Diabetol Int"},{"key":"10.1016\/j.diabres.2024.111799_b0035","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1172\/JCI94549","article-title":"Autoreactive T cells in type 1 diabetes","volume":"127","author":"Pugliese","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2024.111799_b0040","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature03523","article-title":"Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice","volume":"435","author":"Nakayama","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.diabres.2024.111799_b0045","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/eji.1830240820","article-title":"Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice","volume":"24","author":"Wegmann","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.diabres.2024.111799_b0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1172\/JCI8525","article-title":"A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin","volume":"107","author":"Alleva","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2024.111799_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108260","article-title":"Significance of peripheral mononuclear cells producing interferon-gamma in response to insulin B:9\u201323-related peptides in subtypes of type 1 diabetes","volume":"208","author":"Oikawa","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.diabres.2024.111799_b0060","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2337\/diacare.16.5.780","article-title":"Immunogenetic and clinical characterization of slowly progressive IDDM","volume":"16","author":"Kobayashi","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2024.111799_b0065","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2147\/DMSO.S191007","article-title":"Slowly progressive type 1 diabetes mellitus: current knowledge and future perspectives","volume":"12","author":"Nishimura","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.diabres.2024.111799_b0070","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1530\/EJE-14-0342","article-title":"High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7)","volume":"171","author":"Zampetti","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabres.2024.111799_b0075","first-page":"1288","article-title":"UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes","volume":"350","author":"Turner","year":"1997","journal-title":"UK Prospective Diabetes Study Group Lancet"},{"key":"10.1016\/j.diabres.2024.111799_b0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/jaut.1998.0261","article-title":"High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients","volume":"12","author":"Kasuga","year":"1999","journal-title":"J Autoimmun"},{"key":"10.1016\/j.diabres.2024.111799_b0085","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s001250100602","article-title":"Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA)","volume":"44","author":"Lohmann","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2024.111799_b0090","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1210\/jc.2009-1733","article-title":"Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes","volume":"95","author":"Kawasaki","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2024.111799_b0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13340-015-0211-5","article-title":"Predictive value of titer of GAD antibodies for further progression of beta cell dysfunction in slowly progressive insulin-dependent (type 1) diabetes (SPIDDM)","volume":"7","author":"Tanaka","year":"2016","journal-title":"Diabetol Int"},{"key":"10.1016\/j.diabres.2024.111799_b0100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1507\/endocrj.EJ16-0328","article-title":"Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state","volume":"64","author":"Oikawa","year":"2017","journal-title":"Endocr J"},{"key":"10.1016\/j.diabres.2024.111799_b0105","first-page":"1551","article-title":"A study on the correlation between GAD antibody titers measured by ELISA kit and RIA Kit","volume":"72","author":"Oikawa","year":"2015","journal-title":"Jpn J Med Pharm Sci"},{"key":"10.1016\/j.diabres.2024.111799_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13340-014-0199-2","article-title":"Diagnostic criteria for slowly progressive insulin-dependent (type 1) diabetes mellitus (SPIDDM) (2012): report by the committee on slowly progressive insulin-dependent (type 1) diabetes mellitus of the Japan diabetes society","volume":"6","author":"Tanaka","year":"2015","journal-title":"Diabetol Int"},{"key":"10.1016\/j.diabres.2024.111799_b0115","doi-asserted-by":"crossref","first-page":"e2124","DOI":"10.1210\/clinem\/dgab912","article-title":"Clinical significance of insulin peptide-specific interferon-gamma-related immune responses in ketosis-prone type 2 diabetes","volume":"107","author":"Satomura","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2024.111799_b0120","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1507\/endocrj.K10E-399","article-title":"Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes","volume":"58","author":"Saisho","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/j.diabres.2024.111799_b0125","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00125-009-1539-9","article-title":"Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset","volume":"52","author":"Kawabata","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2024.111799_b0130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.diabres.2008.01.024","article-title":"Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)\u2013a 5-year follow-up of the Ehime study","volume":"80","author":"Murao","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2024.111799_b0135","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.2337\/dc08-0235","article-title":"GAD65 autoantibody responses in Japanese latent autoimmune diabetes in adult patients","volume":"31","author":"Maruyama","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2024.111799_b0140","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/iep.12437","article-title":"Autoantibodies directed against glutamate decarboxylase interfere with glucose-stimulated insulin secretion in dispersed rat islets","volume":"103","author":"Kamat","year":"2022","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.diabres.2024.111799_b0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1464-5491.2007.02316.x","article-title":"The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus","volume":"25","author":"van Deutekom","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2024.111799_b0150","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa205","article-title":"Decline pattern of beta-cell function in adult-onset latent autoimmune diabetes: an 8-year prospective study","volume":"105","author":"Li","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2024.111799_b0155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2337\/dc14-1770","article-title":"Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3)","volume":"38","author":"Liu","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2024.111799_b0160","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/jdi.13980","article-title":"Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes","volume":"14","author":"Kawasaki","year":"2023","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.diabres.2024.111799_b0165","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/jdi.12996","article-title":"Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity","volume":"10","author":"Kawasaki","year":"2019","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.diabres.2024.111799_b0170","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2337\/db06-1715","article-title":"GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes","volume":"56","author":"Mayr","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2024.111799_b0175","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s00125-014-3294-9","article-title":"GAD autoantibody affinity in schoolchildren from the general population","volume":"57","author":"Bender","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2024.111799_b0180","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2337\/dc13-1719","article-title":"GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial","volume":"37","author":"Krause","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2024.111799_b0185","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/jdi.14178","article-title":"Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes","volume":"15","author":"Kawasaki","year":"2024","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.diabres.2024.111799_b0190","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1530\/EJE-10-0427","article-title":"Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults","volume":"163","author":"Maioli","year":"2010","journal-title":"Eur J Endocrinol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724007095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724007095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T16:41:43Z","timestamp":1724517703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822724007095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":38,"alternative-id":["S0168822724007095"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111799","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High glutamic acid decarboxylase antibody titers may be associated with a decline in \u03b2-cell function over time and future insulin deficiency in latent autoimmune diabetes in adults","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111799"}}